ConductScience.org, home

Paper26730486

The potential of liquid biopsies.

Buder A and 2 others. Curr Opin Oncol, 2016. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. The potential of liquid biopsies. Papers, record 26730486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26730486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The potential of liquid biopsies.
PubMed
Journal
Curr Opin Oncol
PubMed
Year
2016
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
1.64
iCite
Revised in PubMed
2022-03-18
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Buder AAnna
2Tomuta CChristian
3Filipits MMartin

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Carcinoma, Non-Small-Cell LungMajor topic
DNA, NeoplasmMajor topic
Lung NeoplasmsMajor topic
Antineoplastic Agents
ErbB Receptors
Exosomes
Humans
Neoplastic Cells, Circulating
Protein Kinase Inhibitors
Tumor Burden

Source PubMed

Download CSV of topics

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
39775010Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCR.Sci Rep2025https://conductscience.org/library/papers/39775010PubMed
37450123Role of Liquid Biopsies in Rheumatoid Arthritis.Methods Mol Biol2023https://conductscience.org/library/papers/37450123PubMed
37450116Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy.Methods Mol Biol2023https://conductscience.org/library/papers/37450116PubMed
37444638Epidermal Growth Factor Receptor T790M Mutation Testing in Non-Small Cell Lung Cancer: An International Collaborative Study to Assess Molecular EGFR T790M Testing in Liquid Biopsy.Cancers (Basel)2023https://conductscience.org/library/papers/37444638PubMed
36768828Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs.Int J Mol Sci2023https://conductscience.org/library/papers/36768828PubMed
35582281Liquid biopsies in myeloid malignancies.Cancer Drug Resist2019https://conductscience.org/library/papers/35582281PubMed
34514090Progress and application of circulating tumor cells in non-small cell lung cancer.Mol Ther Oncolytics2021https://conductscience.org/library/papers/34514090PubMed
34445645Cell-Free DNA in Rheumatoid Arthritis.Int J Mol Sci2021https://conductscience.org/library/papers/34445645PubMed
33995103Extracellular Vesicles: A Novel Tool Facilitating Personalized Medicine and Pharmacogenomics in Oncology.Front Pharmacol2021https://conductscience.org/library/papers/33995103PubMed
33919291Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients.Biomolecules2021https://conductscience.org/library/papers/33919291PubMed
33918661Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review.Cancers (Basel)2021https://conductscience.org/library/papers/33918661PubMed
33642890Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients.Clin Med Insights Oncol2021https://conductscience.org/library/papers/33642890PubMed
33352935Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma.Cancers (Basel)2020https://conductscience.org/library/papers/33352935PubMed
32537885Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma.Cancer Med2020https://conductscience.org/library/papers/32537885PubMed
32420063EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib.Transl Lung Cancer Res2020https://conductscience.org/library/papers/32420063PubMed
32365836The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review.Cancers (Basel)2020https://conductscience.org/library/papers/32365836PubMed
32206157Cell-Free Circulating Tumour DNA Blood Testing to Detect EGFR T790M Mutation in People With Advanced Non-Small Cell Lung Cancer: A Health Technology Assessment.Ont Health Technol Assess Ser2020https://conductscience.org/library/papers/32206157PubMed
31815659Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy.J Hematol Oncol2019https://conductscience.org/library/papers/31815659PubMed
31433117Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment.Cancer Med2019https://conductscience.org/library/papers/31433117PubMed
31096692Challenges in the Isolation and Proteomic Analysis of Cancer Exosomes-Implications for Translational Research.Proteomes2019https://conductscience.org/library/papers/31096692PubMed

See all 35 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26730486

GET https://conductscience.org/api/papers/v1/26730486/cited_by?page=2